BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$665M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$536M |
| 3 |
Cadence Design Systems
CDNS
|
+$193M |
| 4 |
Goldman Sachs
GS
|
+$183M |
| 5 |
BP
BP
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.62B |
| 2 |
DuPont de Nemours
DD
|
+$722M |
| 3 |
Visa
V
|
+$524M |
| 4 |
Amazon
AMZN
|
+$500M |
| 5 |
NVIDIA
NVDA
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.16% |
| 2 | Healthcare | 6.66% |
| 3 | Consumer Discretionary | 5.8% |
| 4 | Financials | 5.1% |
| 5 | Communication Services | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
iShares MSCI Singapore ETF
EWS
$1.16B
| $119K | ﹤0.01% |
6,500
-2,389
| -27% | -$44.7K |
|
3177
CAE Inc. Common Shares
CAE
$8.47B
| $119K | ﹤0.01% |
5,104
-5,487
| -52% | -$127K |
|
3178
Theravance Biopharma
TBPH
$878M
| $119K | ﹤0.01% |
13,794
-2,488
| -15% | -$24K |
|
3179
MVB Financial
MVBF
$397M
| $119K | ﹤0.01% |
5,262
+1,350
| +35% | +$31.9K |
|
3180
Greene County Bancorp
GCBC
$595M
| $118K | ﹤0.01% |
4,917
+3,137
| +176% | +$94.5K |
|
3181
Establishment Labs
ESTA
$2.25B
| $118K | ﹤0.01% |
2,409
-79,450
| -97% | -$4.75M |
|
3182
Gaotu Techedu
GOTU
$401M
| $116K | ﹤0.01% |
42,111
+9,411
| +29% | +$29.4K |
|
3183
Outlook Therapeutics
OTLK
$166M
| $115K | ﹤0.01% |
26,092
+24,070
| +1,190% | +$533K |
|
3184
CorMedix
CRMD
$639M
| $115K | ﹤0.01% |
31,142
+18,958
| +156% | +$75.4K |
|
|
CSTR
3185
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $115K | ﹤0.01% |
8,107
+2,775
| +52% | +$38.1K |
|
3186
MBIA
MBI
$262M
| $115K | ﹤0.01% |
15,933
+2,800
| +21% | +$23.3K |
|
3187
Sutro Biopharma
STRO
$353M
| $115K | ﹤0.01% |
3,310
+648
| +24% | +$28.2K |
|
3188
Peoples Financial Services
PFIS
$717M
| $114K | ﹤0.01% |
2,853
+1,046
| +58% | +$47K |
|
|
HT
3189
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $114K | ﹤0.01% |
11,576
+670
| +6% | +$5.13K |
|
3190
Ducommun
DCO
$3.01B
| $114K | ﹤0.01% |
2,620
-6,362
| -71% | -$289K |
|
3191
Martin Midstream Partners
MMLP
$89.6M
| $113K | ﹤0.01% |
40,810
+8,212
| +25% | +$21.2K |
|
3192
The ONE Group
STKS
$56.8M
| $113K | ﹤0.01% |
20,582
+10,546
| +105% | +$71.6K |
|
3193
Oppenheimer Holdings
OPY
$1.23B
| $113K | ﹤0.01% |
2,950
-2,062
| -41% | -$80.3K |
|
|
TVRD
3194
Tvardi Therapeutics
TVRD
$22.1M
| $113K | ﹤0.01% |
1,862
-294
| -14% | -$27.6K |
|
3195
Boston Omaha
BOC
$431M
| $112K | ﹤0.01% |
6,860
-3,014
| -31% | -$54.1K |
|
3196
CALL
Nutanix
NTNX
$18.4B
| $112K | ﹤0.01% |
32
-3
| -9% | -$94 |
|
3197
American Realty Investors
ARL
$246M
| $111K | ﹤0.01% |
7,610
+1,599
| +27% | +$30.1K |
|
|
AL
3198
DELISTED
Air Lease Corp
AL
| $111K | ﹤0.01% |
2,820
-51,582
| -95% | -$2.12M |
|
3199
Fresenius Medical Care
FMS
$12.6B
| $111K | ﹤0.01% |
5,150
+126
| +3% | +$3.06K |
|
3200
Stoke Therapeutics
STOK
$2.02B
| $111K | ﹤0.01% |
28,152
+20,847
| +285% | +$137K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2023 Portfolio in Review
As of Q3 2023, BNP Paribas Financial Markets held 4,107 positions worth $77.8B, down 2.7% from $80B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets withdrew a net $4.87B in Q3 2023, closing 194 positions and reducing 1,203 holdings. Its most notable exit was Direxion NASDAQ-100 Equal Weighted Index ETF, an estimated $15.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Tower Semiconductor worth $7.33M.
- BNP Paribas Financial Markets's largest Q3 2023 buy was Tower Semiconductor: 298,400 shares worth $7.33M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2023, an estimated $665M increase.
- BNP Paribas Financial Markets's biggest Q3 2023 reduction was Alibaba, cutting an estimated $1.62B.
- BNP Paribas Financial Markets fully exited Direxion NASDAQ-100 Equal Weighted Index ETF in Q3 2023, selling an estimated $15.4M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $77.8B portfolio in Q3 2023.
- BNP Paribas Financial Markets opened 199 new positions and closed 194 in Q3 2023.
- BNP Paribas Financial Markets's portfolio value fell 2.7% quarter-over-quarter to $77.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2023, filed 14 Nov 2023.